| Elevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancer. | lung, |
| The results of this research suggested that SHIP2 expression was correlated with malignant phenotypes of non-small cell lung cancer and may thus serve as a poor prognostic factor and valuable oncogene for NSCLC. | lung, |
| the expression and intrinsic phosphatase activity of the lipid phosphatase SHIP2 is increased in human colorectal cancer, and that increased expression within a large cohort of CRC patient is correlated to a worse patient survival. SHIP2 functions as an oncogene, by enhancing cell migration and invasion, and reducing cell adhesion in colorectal cancer cells. | colorectal, |